Related Experiment Video
Updated: Aug 21, 2026
RhoC GTPase Activation Assay
Published on: August 22, 2010
Identification and characterization of a lymphocytic Rho-GTPase effector: rhotekin-2
F M Collier1, C C Gregorio-King, T J Gough
1Douglas Hocking Research Institute, Barwon Health, The Geelong Hospital, Geelong, Victoria 3220, Australia. fionac@barwonhealth.org.au
Abstract:
Rhotekin belongs to the group of proteins containing a Rho-binding domain that are target peptides (effectors) for the Rho-GTPases. We previously identified a novel cDNA with homology to human rhotekin and in this study we cloned and characterized the coding region of this novel 12-exon gene. The ORF encodes a 609 amino-acid protein comprising a Class I Rho-binding domain and pleckstrin homology (PH) domain. Cellular cDNA expression of this new protein, designated Rhotekin-2 (RTKN2), was shown in the cytosol and nucleus of CHO cells. Using bioinformatics and RTPCR we identified three major splice variants, which vary in both the Rho-binding and PH domains. Real-time PCR studies showed exclusive RTKN2 expression in pooled lymphocytes and further purification indicated sole expression in CD4(pos) T-cells and bone marrow-derived B-cells. Gene expression was increased in quiescent T-cells but negligible in activated proliferating cells. In malignant samples expression was absent in myeloid leukaemias, low in most B-cell malignancies and CD8(pos) T-cell malignancies, but very high in CD4(pos)/CD8(pos) T-lymphoblastic lymphoma. As the Rho family is critical in lymphocyte development and function, RTKN2 may play an important role in lymphopoiesis.
Insights
Researchers identified Rhotekin-2 (RTKN2), a novel protein involved in Rho-GTPase signaling. RTKN2 is primarily expressed in T-cells and B-cells, with altered expression in certain leukemias and lymphomas, suggesting a role in lymphopoiesis.
Area of Science:
- Molecular Biology
- Cell Biology
- Immunology
Background:
- Rhotekin proteins are effectors for Rho-GTPases, crucial for cellular signaling.
- A novel gene homologous to human rhotekin was previously identified.
Purpose of the Study:
- To clone and characterize the coding region of the novel rhotekin gene.
- To investigate the expression patterns and splice variants of the new protein, Rhotekin-2 (RTKN2).
Main Methods:
- Cloning and characterization of a 12-exon gene.
- Analysis of the open reading frame (ORF) encoding a 609 amino-acid protein.
- Bioinformatics and RT-PCR to identify splice variants.
- Real-time PCR to determine gene expression in various cell types and conditions.
Main Results:
- The novel protein, Rhotekin-2 (RTKN2), possesses a Rho-binding domain and a pleckstrin homology (PH) domain.
- Three major splice variants of RTKN2 were identified, differing in these domains.
- RTKN2 expression is exclusive to lymphocytes, particularly CD4+ T-cells and B-cells.
- Expression is elevated in quiescent T-cells and significantly altered in various hematologic malignancies.
Conclusions:
- RTKN2 is a novel Rho-binding protein with distinct splice variants.
- Its specific expression in lymphocytes suggests a role in lymphopoiesis.
- Altered RTKN2 expression in malignancies may indicate its involvement in disease pathogenesis.
More Related Videos
Related Concept Videos
01:24Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
01:26Receptor Tyrosine Kinases
01:14Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
01:00Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...